UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000031594 |
|---|---|
| Receipt number | R000036065 |
| Scientific Title | Measurement of central conduction time in patients with neurological disorders using transcranial magnetic stimulation |
| Date of disclosure of the study information | 2018/03/10 |
| Last modified on | 2019/03/06 11:31:29 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Measurement of central conduction time in patients with neurological disorders using transcranial magnetic stimulation
Acronym
Transcranial magnetic stimulation in neurological patients
Scientific Title
Measurement of central conduction time in patients with neurological disorders using transcranial magnetic stimulation
Scientific Title:Acronym
Transcranial magnetic stimulation in neurological patients
Region
| Japan |
Condition
Condition
patients with neurological disorders
Classification by specialty
| Neurology |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
To develop a method to measure central condution time in patients with neurological disorders in the clinical setting
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
central conduction time (central and peripheral latencies of the motor evoked potential), amplitude of the motor evoked potential and how they deviate from normal values depending on the diagnosis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
patients with neurological disorders
Key exclusion criteria
cervical spondylosis, metal inside the body
subjects who cannot cooperate, non-adult subjects
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yasuo Terao |
Organization
Faculty of Medicine, Kyorin University
Division name
Department of Cell Physiology
Zip code
Address
6-20-2 Shinkawa, Mitaka, Tokyo
TEL
+81422475511
yterao-tky@umin.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yasuo Terao |
Organization
Faculty of Medicine, Kyorin University
Division name
Department of Cell Physiology
Zip code
Address
6-20-2 Shinkawa, Mitaka, Tokyo
TEL
+81422475511
Homepage URL
yterao-tky@umin.ac.jp
Sponsor or person
Institute
Faculty of Medicine, Kyorin University
Institute
Department
Personal name
Funding Source
Organization
Japan Society for the promotion of Science, Ministry of Education, Science and Culture
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 03 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2017 | Year | 08 | Month | 03 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2022 | Year | 08 | Month | 03 | Day |
Date of closure to data entry
| 2022 | Year | 08 | Month | 03 | Day |
Date trial data considered complete
| 2022 | Year | 08 | Month | 03 | Day |
Date analysis concluded
| 2027 | Year | 08 | Month | 03 | Day |
Other
Other related information
Central motor conduction time measured by transcranial magnetic stimulation
Management information
Registered date
| 2018 | Year | 03 | Month | 05 | Day |
Last modified on
| 2019 | Year | 03 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036065
